Ad is loading...
GQGPX
Price
$16.96
Change
-$0.05 (-0.29%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

GQGPX vs RNWFX

Header iconGQGPX vs RNWFX Comparison
Open Charts GQGPX vs RNWFXBanner chart's image
GQG Partners Emerging Markets Equity I
Price$16.96
Change-$0.05 (-0.29%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
GQGPX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GQGPX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GQGPX is a StrongBuy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. GQGPX (22.2B). GQGPX pays higher dividends than RNWFX: GQGPX (2.30) vs RNWFX (1.51). GQGPX was incepted earlier than RNWFX: GQGPX (8 years) vs RNWFX (23 years). GQGPX is a more actively managed with annual turnover of: 88.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than GQGPX: RNWFX (250) vs GQGPX (2500). GQGPX annual gain was more profitable for investors over the last year : 16.01 vs. RNWFX (11.54). GQGPX return over 5 years is better than : 47.47 vs. RNWFX (17.17).
GQGPXRNWFXGQGPX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years23 years-
Gain YTD7.6837.099108%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets22.2B60.9B36%
Annual Yield % from dividends2.301.51153%
Returns for 1 year16.0111.54139%
Returns for 3 years3.85-14.55-26%
Returns for 5 years47.4717.17277%
Returns for 10 yearsN/A41.00-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics